Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress

Frontiers in Cellular Neuroscience

Volumn 8, Issue FEB, 2014, Pages

  Rojas, Fabiola ^a   Cortes, Nicole ^a   Abarzua, Sebastian ^a   Dyrda, Agnieszka ^a   van Zundert, Brigitte ^a  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

ALS; Anti oxidants; Degeneration; Motor neuron; Non cell autonomous; ROS RNS

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; ESCULETIN; MEXILETINE; REACTIVE OXYGEN METABOLITE; RESVERATROL; RILUZOLE; SODIUM CHANNEL; SPERMIDINE; TROLOX C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL COUNT; CELL LABELING; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MOTOR PERFORMANCE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RAT;

EID: 84893574224     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00024     Document Type: Article

References (85)

1. Abel, O., Powell, J. F., Andersen, P. M., and Al-Chalabi, A. (2012). ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 33, 1345-1351. doi: 10.1002/humu.22157
2. Aman, T. K., Grieco-Calub, T. M., Chen, C., Rusconi, R., Slat, E. A., Isom, L. L., et al. (2009). Regulation of persistent Na current by interactions between beta subunits of voltage-gated Na channels. J. Neurosci. 29, 2027-2042. doi: 10.1523/JNEUROSCI.4531-08.2009
3. Appaix, F., Girod, S., Boisseau, S., Romer, J., Vial, J. C., Albrieux, M., et al. (2012). Specific in vivo staining of astrocytes in the whole brain after intravenous injection of sulforhodamine dyes. PLoS ONE 7:e35169. doi: 10.1371/journal.pone.0035169
4. Ascherio, A., Weisskopf, M. G., O'reilly, E. J., Jacobs, E. J., McCullough, M. L., Calle, E. E., et al. (2005). Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann. Neurol. 57, 104-110. doi: 10.1002/ana.20316
5. Barber, S. C., Higginbottom, A., Mead, R. J., Barber, S., and Shaw, P. J. (2009). An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic. Biol. Med. 46, 1127-1138. doi: 10.1016/j.freeradbiomed.2009.01.019
6. Barber, S. C., and Shaw, P. J. (2010). Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 48, 629-641. doi: 10.1016/j.freeradbiomed.2009.11.018
7. Baur, J. A., and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506. doi: 10.1038/nrd2060
8. Beckman, J. S., Estévez, A. G., Crow, J. P., and Barbeito, L. (2001). Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 24, S15-S20. doi: 10.1016/S0166-2236(00)01981-0
9. Bellingham, M. C. (2011). A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci. Ther. 17, 4-31. doi: 10.1111/j.1755-5949.2009.00116.x
10. Bento-Abreu, A., van Damme, P., van Den Bosch, L., and Robberecht, W. (2010). The neurobiology of amyotrophic lateral sclerosis. Eur. J. Neurosci. 31, 2247-2265. doi: 10.1111/j.1460-9568.2010.07260.x
11. Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., et al. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. doi: 10.1126/science.1123511
12. Bruijn, L. I., Miller, T. M., and Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749. doi: 10.1146/annurev.neuro.27.070203.144244
13. Carter, B. J., Anklesaria, P., Choi, S., and Engelhardt, J. F. (2009). Redox modifier genes and pathways in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 11, 1569-1586. doi: 10.1089/ARS.2008.2414
14. Cassina, P., Cassina, A., Pehar, M., Castellanos, R., Gandelman, M., de León, A., et al. (2008). Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 28, 4115-4122. doi: 10.1523/JNEUROSCI.5308-07.2008
15. Castillo, K., Nassif, M., Valenzuela, V., Rojas, F., Matus, S., Mercado, G., et al. (2013). Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9, 1308-1320. doi: 10.4161/auto.25188
16. Catterall, W. A., Goldin, A. L., and Waxman, S. G. (2005). International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397-409. doi: 10.1124/pr.57.4.4
17. Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., et al. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117. doi: 10.1126/science.1086071
18. Cleveland, D. W., and Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806-819. doi: 10.1038/35097565
19. Cozzolino, M., Pesaresi, M. G., Gerbino, V., Grosskreutz, J., and Carrì, M. T. (2012). Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid. Redox Signal. 17, 1277-1330. doi: 10.1089/ars.2011.4328
20. Desnuelle, C., Dib, M., Garrel, C., and Favier, A. (2001). A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2, 9-18. doi: 10.1080/146608201300079364
21. Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., and Eggan, K. (2007). Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10, 608-614. doi: 10.1038/nn1885
22. Distelmaier, F., Valsecchi, F., Forkink, M., van Emst-de Vries, S., Swarts, H. G., Rodenburg, R. J., et al. (2012). Trolox-sensitive reactive oxygen species regulate mitochondrial morphology, oxidative phosphorylation and cytosolic calcium handling in healthy cells. Antioxid. Redox Signal. 17, 1657-1669. doi: 10.1089/ars.2011.4294
23. Drechsel, D. A., Estévez, A. G., Barbeito, L., and Beckman, J. S. (2012). Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox. Res. 22, 251-264. doi: 10.1007/s12640-012-9322
24. ElBasiouny, S. M., Schuster, J. E., and Heckman, C. J. (2010). Persistent inward currents in spinal motoneurons: important for normal function but potentially harmful after spinal cord injury and in amyotrophic lateral sclerosis. Clin. Neurophysiol. 121, 1669-1679. doi: 10.1016/j.clinph.2009.12.041
25. Estévez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., et al. (1999). Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498-2500.
26. Ezzi, S. A., Urushitani, M., and Julien, J. P. (2007). Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 102, 170-178. doi: 10.1111/j.1471-4159.2007.04531.x
27. Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., and Shaw, P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. doi: 10.1038/nrneurol.2011.152
28. Fleidervish, I. A., Goldberg, Y., and Ovsyshcher, I. E. (2008). Bolus injection of acetylcholine terminates atrial fibrillation in rats. Eur. J. Pharmacol. 579, 326-329. doi: 10.1016/j.ejphar.2007.11.010
29. +currents increases the excitability of rat neocortical pyramidal neurons. J. Physio. 528, 291-304. doi: 10.1111/j.1469-7793.2000.00291.x
30. Fritz, E., Izaurieta, P., Weiss, A., Mir, F. R., Rojas, P., Gonzalez, D., et al. (2013). Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J. Neurophysiol. 109, 2803-2814. doi: 10.1152/jn.00500.2012
31. Ghiselli, A., Serafini, M., Maiani, G., Azzini, E., and Ferro-Luzzi, A. (1995). A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic. Biol. Med. 18, 29-36. doi: 10.1016/0891-5849(94)00102-P
32. Goldin, A. L. (2003). Mechanisms of sodium channel inactivation. Curr. Opin. Neurobiol. 13, 284-290. doi: 10.1016/S0959-4388(03)00065-5
33. Gomes, A., Fernandes, E., and Lima, J. L. (2005). Fluorescence probes used for detection of reactive oxygen species. J. Biochem. Biophys. Methods 65, 45-80. doi: 10.1016/j.jbbm.2005.10.003
34. Graf, M., Ecker, D., Horowski, R., Kramer, B., Riederer, P., Gerlach, M., et al. (2005). High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J. Neural Transm. 112, 649-660. doi: 10.1007/s00702-004-0220-1
35. Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., et al. (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157. doi: 10.1002/ana.410390203
36. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775. doi: 10.1126/science.8209258
37. Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., et al. (2011). Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824-828. doi: 10.1038/nbt.1957
38. Hammarström, A. K., and Gage, P. W. (2000). Oxygen-sensing persistent sodium channels in rat hippocampus. J. Physiol. 529, 107-118. 10.1111/j.1469-7793.2000.00107. x
39. Harraz, M. M., Marden, J. J., Zhou, W., Zhang, Y., Williams, A., Sharov, V. S., et al. (2008). SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 118, 659-670. doi: 10.1172/JCI34060
40. Harraz, M. M., Park, A., Abbott, D., Zhou, W., Zhang, Y., and Engelhardt, J. F. (2007). MKK6 phosphorylation regulates production of superoxide by enhancing Rac GTPase activity. Antioxid. Redox Signal. 9, 1803-1813. doi: 10.1089/ars.2007.1579
41. Ilieva, H., Polymenidou, M., and Cleveland, D. W. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772. doi: 10.1083/jcb.200908164
42. Kalyanaraman, B., Darley-Usmar, V., Davies, K. J., Dennery, P. A., Forman, H. J., Grisham, M. B., et al. (2012). Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med. 52, 1-6. doi: 10.1016/j.freeradbiomed.2011.09.030
43. Kaneko, T., Tahara, S., and Takabayashi, F. (2003). Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biol. Pharm. Bull. 26, 840-844. doi: 10.1248/bpb.26.840
44. Kassmann, M., Hansel, A., Leipold, E., Birkenbeil, J., Lu, S. Q., Hoshi, T., et al. (2008). Oxidation of multiple methionine residues impairs rapid sodium channel inactivation. Pflugers Arch. 456, 1085-1095. doi: 10.1007/s00424-008-0477-6
45. Khaldy, H., Escames, G., León, J., Vives, F., Luna, J. D., and Acuña-Castroviejo, D. (2000). Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro. J. Pineal Res. 29, 100-107. doi: 10.1034/j.1600-079X.2000.290206.x
46. Kuo, J. J., Siddique, T., Fu, R., and Heckman, C. J. (2005). Increased persistent Na+ current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 563, 843-854. doi: 10.1113/jphysiol.2004.074138
47. Igaz, L. M., Kwong, L. K., Lee, E. B., Chen-Plotkin, A., Swanson, E., Unger, T., et al. (2011). Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest. 121, 726-738. doi: 10.1172/JCI44867
48. Lin, W. L., Wang, C. J., Tsai, Y. Y., Liu, C. L., Hwang, J. M., and Tseng, T. H. (2000). Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch. Toxicol. 74, 467-472. doi: 10.1007/s002040000148
49. Ling, S. C., Polymenidou, M., and Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416-438. doi: 10.1016/j.neuron.2013.07.033
50. Lobsiger, C. S., Boillee, S., McAlonis-Downes, M., Khan, A. M., Feltri, M. L., Yamanaka, K., et al. (2009). Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl. Acad. Sci. U.S.A. 106, 4465-4470. doi: 10.1073/pnas.0813339106
51. Marchetto, M. C., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G., and Gage, F. H. (2008). Non-cell-autonomous effect of human SOD1G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649-657. doi: 10.1016/j.stem.2008.10.001
52. Marden, J. J., Harraz, M. M., Williams, A. J., Nelson, K., Luo, M., Paulson, H., et al. (2007). Redox modifier genes in amyotrophic lateral sclerosis in mice. J. Clin. Invest. 117, 2913-2319. doi: 10.1172/JCI31265
53. Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A., et al. (2007). Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 500, 20-46. doi: 10.1002/cne.21160
54. Meyer, K., Ferraiuolo, L., Miranda, C. J., Likhite, S., McElroy, S., Renusch, S., et al. (2014). Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. U.S.A. 111, 829-832. doi: 10.1073/pnas.1314085111
55. Mumbengegwi, D. R., Li, Q., Li, C., Bear, C. E., and Engelhardt, J. F. (2008). Evidence for a superoxide permeability pathway in endosomal membranes. Mol. Cell. Biol. 28, 3700-3712. doi: 10.1128/MCB.02038-07
56. Myhre, O., Andersen, J. M., Aarnes, H., and Fonnum, F. (2003). Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 65, 1575-1582. doi: 10.1016/S0006-2952(03)00083-2
57. Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., et al. (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622. doi: 10.1038/nn1876
58. Nani, F., Cifra, A., and Nistri, A. (2010). Transient oxidative stress evokes early changes in the functional properties of neonatal rat hypoglossal motoneurons in vitro. Eur. J. Neurosci. 31, 951-966. doi: 10.1111/j.1460-9568.2010.07108.x
59. Olschewski, A., Schnoebel-Ehehalt, R., Li, Y., Tang, B., Bräu, M. E., and Wolff, M. (2009). Mexiletine and lidocaine suppress the excitability of dorsal horn neurons. Anesth. Analg. 109, 258-264. doi: 10.1213/ane.0b013e3181a3d5d8
60. Pambo-Pambo, A., Durand, J., and Gueritaud, J. P. (2009). Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J. Neurophysiol. 102, 3627-3642. doi: 10.1152/jn.00482.2009
61. Pasinelli, P., and Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723. doi: 10.1038/nrn1971
62. Pehar, M., Cassina, P., Vargas, M. R., Castellanos, R., Viera, L., Beckman, J. S., et al. (2004). Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem. 89, 464-473. doi: 10.1111/j.1471-4159.2004.02357.x
63. Pieri, M., Carunchio, I., Curcio, L., Mercuri, N. B., and Zona, C. (2009). Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol. 215, 368-379. doi: 10.1016/j.expneurol.2008.11.002
64. Quinlan, K. A., Schuster, J. E., Fu, R., Siddique, T., and Heckman, C. J. (2011). Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 589, 2245-2260. doi: 10.1113/jphysiol.2010.200659
65. Ragsdale, D. S., McPhee, J. C., Scheuer, T., and Catterall, W. A. (1994). Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 265, 1724-1728. doi: 10.1126/science.8085162
66. Ramírez-Jarquín, U. N., Lazo-Gómez, R., Tovar-Y-Romo, L. B., and Tapia, R. (2013). Spinal inhibitory circuits and their role in motor neuron degeneration. Neuropharmacology. doi: 10.1016/j.neuropharm.2013.10.003. [Epub ahead of print].
67. Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., and Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 92, 689-693. doi: 10.1073/pnas.92.3.689
68. Schuster, J. E., Fu, R., Siddique, T., and Heckman, C. J. (2011). Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS. J. Neurophysiol. 107, 484-492. doi: 10.1152/jn.00714.2011
69. Sepulveda, F. J., Bustos, F. J., Inostroza, E., Zúñiga, F. A., Neve, R. L., Montecino, M., et al. (2010). Differential roles of NMDA receptor subtypes NR2A and NR2B in dendritic branch development and requirement of RasGRF1. J Neurophysiol. 103, 1758-1770. doi: 10.1152/jn.00823.2009
70. Serio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., et al. (2013). Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. U.S.A. 110, 4697-4702. doi: 10.1073/pnas.1300398110
71. Theiss, R. D., Kuo, J. J., and Heckman, C. J. (2007). Persistent inward currents in rat ventral horn neurones. J. Physiol. 580, 507-522. doi: 10.1113/jphysiol.2006.124123
72. Tucker, J. M., and Townsend, D. M. (2005). Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed. Pharmacother. 59, 380-387. doi: 10.1016/j.biopha.2005.06.005
73. Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., and Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108-118. doi: 10.1038/nn1603
74. van Zundert, B., Izaurieta, P., Fritz, E., and Alvarez, F. J. (2012). Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Cell Biochem. 113, 3301-3312. doi: 10.1002/jcb.24234
75. van Zundert, B., Peuscher, M. H., Hynynen, M., Chen, A., Neve, R. L., Brown, R. H. Jr., et al. (2008). Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 28, 10864-1 0874. doi: 10.1523/JNEUROSCI.1340-08.2008
76. Vargas, M. R., Pehar, M., Cassina, P., Beckman, J. S., and Barbeito, L. (2006). Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J. Neurochem. 97, 687-696. doi: 10.1111/j.1471-4159.2006.03742.x
77. von Lewinski, F., and Keller, B. U. (2005). Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci. 28, 494-500. doi: 10.1016/j.tins.2005.07.001
78. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 106, 18809-18814. doi: 10.1073/pnas.0908767106
79. Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., et al. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 107, 3858-3863. doi: 10.1073/pnas.0912417107
80. Williams, K., (1997). Modulation and block of ion channels: a new biology of polyamines. Cell Signal. 9, 1-13. doi: 10.1016/S0898-6568(96)00089-7
81. Wootz, H., Fitzsimons-Kantamneni, E., Larhammar, M., Rotterman, T. M., Enjin, A., Patra, K., et al. (2013). Alterations in the motor neuron-renshaw cell circuit in the Sod1(G93A) mouse model. J. Comp. Neurol. 521, 1449-1469. doi: 10.1002/cne.23322
82. Wu, D. C., Re, D. B., Nagai, M., Ischiropoulos, H., and Przedborski, S. (2006). The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. U.S.A. 103, 12132-12137. doi: 10.1073/pnas.0603670103
83. Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., et al. (2008a). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253. doi: 10.1038/nn2047
84. Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., et al. (2008b). Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. U.S.A. 105, 7594-7599. doi: 10.1073/pnas.0802556105
85. Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J. P., et al. (2010). Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231-243. doi: 10.1002/glia.20919